# Continuous Infusions vs Scheduled Bolus Infusions

> **NCT03230565** · PHASE4 · RECRUITING · sponsor: **Stanford University** · enrollment: 240 (estimated)

## Conditions studied

- Surgical Procedure, Unspecified
- Pain, Postoperative

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT03230565
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230565, "Continuous Infusions vs Scheduled Bolus Infusions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03230565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*